Kallikrein 9 抗体 (C-Term)
Quick Overview for Kallikrein 9 抗体 (C-Term) (ABIN3043038)
抗原
See all Kallikrein 9 (KLK9) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 236-250, C-Term
-
原理
- Anti-Kallikrein 9/KLK9 Antibody Picoband®
-
序列
- SVCHYLDWIQ EIMEN
-
交叉反应 （详细）
- No cross-reactivity with other proteins
-
产品特性
- Anti-Kallikrein 9/KLK9 Antibody (ABIN3043038). Tested in WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9.
-
亚型
- IgG
-
-
anti-Kallikrein 9 (KLK9) antibody
KLK9 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein 9 (KLK9) (AA 1-250) antibodyKLK9 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Kallikrein 9 (KLK9) (AA 1-250) antibodyKLK9 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein 9 (KLK9) (AA 1-30), (N-Term) antibodyKLK9 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal RB6478 unconjugated
anti-Kallikrein 9 (KLK9) (AA 81-111), (Middle Region) antibodyKLK9 适用: 人 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Kallikrein 9 (KLK9) (AA 82-111) antibodyKLK9 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Western blot, 0.1-0.5 μg/mL, Human
1. Yousef, G. M., Diamandis, E. P. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65: 184-194, 2000. 2. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P., Katsaros, D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 61: 7811-7818, 2001. -
说明
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
浓度
- 500 μg/mL
-
缓冲液
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
储存液
- Thimerosal (Merthiolate), Sodium azide
-
注意事项
- This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
注意事项
- Avoid repeated freezing and thawing.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
有效期
- 12 months
-
-
- Kallikrein 9 (KLK9)
-
别名
- KLK9
-
背景
-
Synonyms: Kallikrein-9;3.4.21.-;Kallikrein-like protein 3;KLK-L3;KLK9;
Tissue Specificity: Skin, thymus, trachea, cerebellum and spinal cord.
Background: KLK9 (kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al. (2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.
Sequence Similarities: Belongs to the peptidase S1 family. Kallikrein subfamily.
-
分子量
- 35 kDa
-
途径
- Complement System
抗原
-
